Artiva Biotherapeutics (ARTV)

Profile

Full Name

Artiva Biotherapeutics, Inc.

Ticker Symbol

ARTV

Exchange

NASDAQ

Country

United States

IPO

Indexes

Not included

Employees

89

Key Details

Price

$2.54

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$251.00K(-99.25% YoY)

Annual EPS

-$5.81(-388.40% YoY)

PE Ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 26, 25 HC Wainwright & Co.
Buy
Mar 25, 25 Wedbush
Outperform
Mar 25, 25 Needham
Buy
Mar 25, 25 Cantor Fitzgerald
Overweight
Dec 30, 24 HC Wainwright & Co.
Buy
Nov 13, 24 Needham
Buy
Aug 30, 24 Needham
Buy
Aug 13, 24 Wedbush
Outperform
Aug 13, 24 TD Cowen
Buy
Aug 13, 24 Needham
Buy

Institutional Ownership

  • What is the ticker symbol for Artiva Biotherapeutics?
  • Does Artiva Biotherapeutics pay dividends?
  • What sector is Artiva Biotherapeutics in?
  • What industry is Artiva Biotherapeutics in?
  • What country is Artiva Biotherapeutics based in?
  • Is Artiva Biotherapeutics in the S&P 500?
  • Is Artiva Biotherapeutics in the NASDAQ 100?
  • Is Artiva Biotherapeutics in the Dow Jones?
  • When was Artiva Biotherapeutics's last earnings report?
  • When does Artiva Biotherapeutics report earnings?
  • Should I buy Artiva Biotherapeutics stock now?

What is the ticker symbol for Artiva Biotherapeutics?

The ticker symbol for Artiva Biotherapeutics is NASDAQ:ARTV

Does Artiva Biotherapeutics pay dividends?

No, Artiva Biotherapeutics does not pay dividends

What sector is Artiva Biotherapeutics in?

Artiva Biotherapeutics is in the Healthcare sector

What industry is Artiva Biotherapeutics in?

Artiva Biotherapeutics is in the Biotechnology industry

What country is Artiva Biotherapeutics based in?

Artiva Biotherapeutics is headquartered in United States

Is Artiva Biotherapeutics in the S&P 500?

No, Artiva Biotherapeutics is not included in the S&P 500 index

Is Artiva Biotherapeutics in the NASDAQ 100?

No, Artiva Biotherapeutics is not included in the NASDAQ 100 index

Is Artiva Biotherapeutics in the Dow Jones?

No, Artiva Biotherapeutics is not included in the Dow Jones index

When was Artiva Biotherapeutics's last earnings report?

Artiva Biotherapeutics's most recent earnings report was on Mar 24, 2025

When does Artiva Biotherapeutics report earnings?

The next expected earnings date for Artiva Biotherapeutics is May 30, 2025

Should I buy Artiva Biotherapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page